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Background: Because lung cancer resection is at the crossroad 
between cancer and high-risk surgery, we hypothesized that the 
patients undergoing lung resection for cancer are exposed to develop 
a post-traumatic stress disorder (PTSD) syndrome-related symptoms.
Methods: Forty-seven adult patients were included in the study. 
Patients were eligible for inclusion if they underwent lung resection 
for suspected cancer, if they were able to speak and read French, 
and if they agreed to be reached for a telephone interview. We 
assessed before, immediately after, and 3 months after surgery the 
presence of symptoms of anxiety and depression (Hospital Anxiety 
and Depression Scale) and PTSD-related symptoms (impact of 
events scale revised [IES-R]). At the 3-month assessment, an IES-R 
score > 22 was used as criteria for predicting the patients at risk of 
 PTSD-related symptoms.
Results: We identified an IES-R score higher than 22 in 24 par-
ticipants (51%). Patients with a preoperatory Hospital Anxiety 
and Depression Scale
anxiety
 score more than 7 (T0) and a maximal 
visual analogic scale score more than 40 during the first 24 hours 
after surgery were more likely to develop PTSD-related symptoms 
at 3-months with odd ratios at 4.61 [1.20–17.73] (p = 0.03) and 1.34 
[1.05–1.75] (p = 0.02).
Conclusion: The prevalence of PTSD-related symptoms after lung 
cancer resection is high, showing that lung cancer patients undergo-
ing surgical resection are at high risk of postprocedure burden. The 
presence of preoperative symptoms of anxiety and acute procedural 
pain during the early postoperative period are strong predictors for 
developing PTSD-related symptoms after lung cancer surgery.
Key Words: Post-traumatic stress disorder, Thoracic surgery, Lung 
resection, Postoperative pain.
(J Thorac Oncol. 2014;9: 362–369)
Post-traumatic stress disorder (PTSD) is a severe anxiety disorder.1 This syndrome has been described to occur after 
exposure to any event, resulting in psychological trauma. This 
event may encompass the threat of death or the loss of physi-
cal, sexual, or psychological integrity. By definition, the symp-
toms of PTSD last more than 1 month and produce significant 
deficiency in social, occupational, or other important fields of 
performance. The early detection of PTSD is critical because its 
occurrence is correlated to a reduced quality of life.2 PTSD and 
mood disorders have been found to frequently occur together. 
Mood disorders can include major depression, bipolar disor-
der, and seasonal affective disorder. They are common in the 
population and much more common among certain groups of 
patients, such as those with PTSD. We sought to assess post-
operative burden by a dimension that can help the clinicians to 
document the disease. PTSD has been described in a wide num-
ber of circumstances, including physical assault, procedural 
pain, or intensive care management.3–5 PTSD is a debilitating 
psychological condition triggered by a major traumatic event, 
such as rape, war, a terrorist act, death of a loved one, a natu-
ral disaster, or a catastrophic accident. It is marked by upset-
ting memories or thoughts of the ordeal, blunting of emotions, 
increased arousal, and sometimes severe personality changes.
PTSD symptoms include hyperalertness, fear and anxi-
ety, nightmares and flashbacks, sight, sound, and smell recol-
lection, avoidance of recall situations, anger and irritability, 
guilt, depression, increased substance abuse, negative world 
view, and decreased sexual activity.
Symptoms usually begin within 3 months of the trauma. 
For a diagnosis of PTSD, symptoms must include: intrusive 
symptoms (flashbacks, sleep disorders: nightmares or night 
terrors, intense distress when exposed to events that are 
associated with the trauma) and at least three of the follow-
ing avoidance symptoms that affect interactions with others 
( trying to avoid thinking or feeling about the trauma, inability 
to remember the event, inability to experience emotion, as well 
as a loss of interest in former pleasures—psychic numbing or 
blunting—and a sense of a shortened future), and evidence of 
increased arousal, including at least two of the following (prob-
lems falling asleep, startle reactions: hyperalertness and strong 
reactions to unexpected noises, memory problems, concentra-
tion problems, moodiness, or violence). The use of the vali-
dated impact of event scale revised (IES-R) has also the major 
strength of exploring these three domains distinctly.
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After hospital stay, symptoms of PTSD are found in 
27% of survivors of intensive care unit (ICU) stay,3 16% of 
survivors of myocardial infarction,4 and 11% of survivors of 
cardiac surgery.5 Predictors of development of symptoms of 
PTSD include female sex, young age, memories of events, and 
use of benzodiazepines in ICU patients,6,7 whereas only cog-
nitive impairments are identified in cardiac surgery patients.8
The specific role of cancer diagnosis should be con-
sidered. After gynecological surgery, the diagnosis of can-
cer and the stage of the disease increase the prevalence of 
 PTSD-related symptoms.9 Lung cancer is the most frequent 
cancer in male patients.10 The literature about quality of life in 
lung cancer survivors is abundant. About half of the patients 
with advanced cancer encounter criteria for a psychiatric dis-
order.11 The initial patient-rated quality of life affects the sub-
sequent survival. For instance, being married seems to be a 
strong factor to an improved survival.12,13
To the best of our knowledge, there are no data avail-
able on the prevalence of PTSD-related symptoms in patients 
undergoing lung surgery for cancer. Our hypothesis was that 
the prevalence of PTSD-related symptoms should be high 
in this population. We sought to determine prevalence and 
risk factors for PTSD-related symptoms after lung cancer 
resection.
PATIENTS AND METHODS
Patients
This is a single-center observational study carried out in 
a thoracic surgery department of a university hospital of 923 
beds. From January 3, 2011 to June 30, 2011, all patients over 
the age of 17 years, with a telephone, receiving social secu-
rity, and scheduled to undergo surgical resection for suspected 
lung cancer were eligible for inclusion. Those excluded from 
the study were patients with progressive neurological disease 
with known cognitive impairment (Alzheimer’s, Parkinson’s, 
multiple sclerosis), patients scheduled for pneumonectomy, 
patients who refused to consent to their participation, patients 
with decompensated somatic or psychiatric illness recently, 
patients who died before follow-up of 3 months, patients 
who could not read or speak French properly, and those 
with criteria of inoperability intraoperatively. The study was 
approved by the Ethics Committee of the French Society for 
Thoracic Surgery and Cardiovascular Surgery (reference: 
 CERC-SFCTV-2010-12-11-17-12-23-LeMa) and written 
informed consent was obtained from participating patients.
Course of Patients
The patients were included by the thoracic surgery anes-
thesiologist team during the preoperative consultation. This 
consultation was scheduled after the surgical consultation 
for a pulmonary resection for suspected cancer. After inclu-
sion, the typical course of a patient consists of a preanesthetic 
visit the day before the surgical intervention. Then, the patient 
undergoes the surgical resection. Next, the patient is first mon-
itored for a short duration in the recovery room and then is 
transferred to the surgical ward before being discharged home 
or to a rehabilitation center. Of note, the surgical unit has a 
full-time clinical psychologist who can meet patients on their 
requests.
The surgery is indicated in accordance with existing 
guidelines for pulmonary resection.14 With regard to surgical 
techniques, open thoracotomy and videothoracoscopy were 
used as required. In those patients in whom the cancer diag-
nosis was not achieved preoperatively, the nature of the tumor 
was confirmed either by frozen section and/or conventional 
pathologic analysis of the resection specimen. In the last case, 
the diagnosis of cancer was confirmed to the patients at the 
first outpatient clinical consultation, usually 1 month after the 
operation. In any case, the patient was informed at the first 
meeting with the surgeon of the high probability of cancer. All 
the surgical procedures consisted of anatomical lung resection 
(segmentectomy, lobectomy) or wedge resection combined 
with mediastinal lymphadenectomy. These procedures were 
performed under general anesthesia after premedication with 
hydroxyzine 1 mg/kg.
When discharged from the recovery room, patients were 
managed in the thoracic surgery ward unless there were com-
plications that required their admission to the polyvalent ICU. 
Postoperative pain control differed depending on the type 
of surgical procedure. With regard to videothoracoscopy, a 
morphine pump with patient control was used. With regard 
to open thoracotomy, an epidural catheter was placed before 
induction. Epidural analgesia was delivered for 5 days after 
surgery using local anesthetics. In case of failure of epidural 
placement, a paravertebral block was placed after surgery. The 
paravertebral block analgesia was based on a continuous infu-
sion of local anesthetics associated with the use of intrave-
nous morphine delivered by a pump. The choice of analgesic 
technique was made by an agreement between the anesthesi-
ologist, surgeon, and patient preference. All patients had an 
active program of physiotherapy, including deep-breathing 
exercises and incentive spirometry in the postoperative period.
Demographic and Clinical Characteristics
We collected age, sex, marital status, education level, 
and occupation. From the medical records were identified: 
body mass index, American Society of Anesthesiology class, 
New York Heart Association functional class, medical history 
(coronary diseases, arrhythmias, diabetes, chronic renal fail-
ure, chronic obstructive pulmonary disease, preoperative use 
of noninvasive ventilation, alcohol consumption, smoking, 
psychiatric history, which was considered positive if patients 
had already have a follow-up), oncologic status (history of 
cancer, cancer surgery, radio, and/or chemotherapy), ongo-
ing treatment (β-blocker, antidepressants, benzodiazepines). 
Then, we collected the prospective data related to: the surgi-
cal procedure (incision, side, extent of pulmonary resection, 
length of stay), the underlying disease (malignancy, primary, 
secondary, nonmalignant disease), the anesthesia (maximal 
visual analogic score (VAS) within the first 48 hours after sur-
gery, type of analgesia), and the postoperative complications 
(pneumonia, clots, leaks, reoperation, renal failure, need for 
chemotherapy or radiotherapy). Postoperative treatments such 
as β-blockers, antidepressants, and use of psychotropic drugs 
(sedatives, hypnotics) were identified.
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Measuring Instruments
The Psychological Well-Being Index (PgWBI) was 
used preoperatively and at 3 months. This general instru-
ment measures the quality of life. This self-administered 
questionnaire was initially validated in healthy subjects to 
assess the psychological well-being. It includes 22 questions 
divided into six distinct dimensions of quality of life: anxiety, 
depressed mood, well-being, self-control, overall health, and 
vitality. This tool has an excellent internal consistency, reli-
ability, and validity in several diseases. Preoperative assess-
ment of PgWBI predicts the postoperative quality of life for 
patients with non–small-cell lung cancer managed with tho-
racic surgery.13
The Hospital Anxiety and Depression Scale (HADS) was 
used preoperatively and at 3 months. This  self-administered 
questionnaire consists of two subscales of seven items each, 
one for anxiety and one for depression, which can be traded 
independently of one another. Each question is scored from 
0 to 3 points, making a maximum of 21 points for each sub-
scale. The HADS takes only 2 to 5 minutes to complete. An 
analysis of scores on both subscales showed that the scores 
of 0 to 7 are normal whereas anxiety scores greater than or 
equal to 8 indicate the possibility of anxiety or depressive 
disorders. Subscales anxiety and depression were found to be 
independent of each other. The HADS is considered as a reli-
able screening tool to detect states of depression and anxiety 
in outpatients.15–17 The elements of the HADS are relevant in 
terms of either generalized anxiety or depression, it excludes 
symptoms that may occur from physical illness, such as 
insomnia, fatigue, or anergy. The HADS has been translated 
into and validated in French language. It is an acceptable, reli-
able, valid, and easy tool to use, convenient for identifying and 
quantifying depression and anxiety.15–17
The IES-R includes 22 items measuring symptoms 
of intrusion, avoidance, and hyperarousal symptoms of 
 post-traumatic stress. Each item is rated from 0 to 4. This is 
a benchmark in the international literature to assess the sub-
jective distress caused by traumatic events. The French ver-
sion has been validated. We used it preoperatively to control 
pre-existing PTSD-related symptoms before the announce-
ment of a cancerous disease or other pre-existing traumatic 
events. The IES-R is a self-assessment questionnaire. It can 
be completed easily by a telephone interview. Respondents are 
asked to identify a stressful life event and a specific one (the 
thoracic surgery–related event) and to indicate how often they 
experienced each of the 22 items in 7 days (0, not at all; 1, 
rarely; 3, sometimes; 4 often). Thus, the score ranges from 0 
to 88. In general, the IES-R is not used to diagnose PTSD, but 
the cutoff scores for a preliminary diagnosis of PTSD-related 
symptoms have been reported in the literature. Although there 
is no threshold for the IES-R, after review of the literature, we 
chose a cutoff at 22 as the best value to be more specific in 
detecting patients at risk of developing PTSD-related symp-
toms. The IES-R was translated into French language.18–20
VAS score was used for pain assessment after surgery. 
A VAS is a measurement tool attempting to measure a charac-
teristic or attitude that is believed to range across a continuum 
of values and cannot easily be directly measured. The goal of 
analgesia was to obtain a VAS score max less than 40. For the 
purpose of our study, we collected the mean and maximal VAS 
scores during the first 24 hours after surgery.
The three questionnaires assessing preoperative symp-
toms of post-traumatic stress, anxiety, and depression, and 
quality of life were distributed at the time of the anesthesia 
consultation. Patients had the option to complete the question-
naires at home and then bring them back to the hospital or 
complete it directly before or after the anesthesia consultation, 
with the help of a physician or nurse. After discharge from 
the thoracic ward, patients completed the questionnaires again 
for the symptoms of PTSD. Three months later, the patients 
were contacted again by mail and the questionnaires had to be 
returned with a prestamped envelope.
Statistical Analysis
Statistics were performed using SPSS version 17.0. 
Quantitative data are expressed as mean ± standard devia-
tion or median (lower and upper quartiles). Percentages were 
calculated for qualitative data. The comparisons of medians 
were performed using the Mann–Whitney U test. The com-
parisons of means were performed using the two-sample 
t-test. Comparisons of proportions were performed with a 
Fisher’s exact test.
After univariate analysis, the variables with significance 
less than 0.1 were included in the logistic regression model, 
also taking into account their clinical relevance. The covari-
ates highly correlating with each other were not included in 
the same multivariate model together. The final level of sig-
nificance was 0.05.
Homer-Lemeshow test is used to test the goodness-of-fit 
of the logistic regression model.21 The χ2 test was applied by 
separating the population into homogeneous risk groups. A p 
value greater than 0.1 indicated a good calibration. The area 
under the receiver operating characteristic is presented for the 
multivariate logistic regression model.22
RESULTS
A total of 68 patients were enrolled in this study. Seventeen 
patients were lost to follow-up, and investigators were unable 
to collect all the data in another four patients. These 21 sub-
jects were excluded from final analysis. As a result, 47 patients 
were included in the cohort (Table 1). Participants consisted 
of 26 male patients and 21 female patients with a mean age of 
59 years (±13). They stayed an average of 9 days (±4) in the 
hospital. Open thoracotomy and minimally invasive resection 
(using videothoracoscopy) were used in 32 cases (68%) and 15 
(32%) cases, respectively. Two patients spent 1 day in the ICU 
for unexpected complications. The diagnosis of lung cancer 
was confirmed in 41 patients. In six patients, the diagnosis was 
changed after pathological examination.
At the 3-month follow-up assessment, an IES-R 
score higher than 22 was found in 24 participants (51%) 
(group A).18–20 In group A, the mean score was 41 (±18), 
as compared with 9 (±8) in those with an IES-R score of 
22 or lesser (group B) (p < 0.001) (Table 1). With regard 
to social, demographic, and surgical characteristics, group 
A did not significantly differ from those with group B. 
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Comorbidity, preoperative chemotherapy, preoperative 
radiotherapy, preoperative uses of β-adrenergic antagonist, 
benzodiazepines, and antidepressant drugs were not associ-
ated with the IES-R score (Table 1). At the 3-month fol-
low-up assessment, anxiety-related symptoms (HADS
anxiety
  
score > 7) and depression-related symptoms (HADS
depression
 
score > 7) were found in 15 (32%) and 12 (26%) patients, 
respectively (Table 2).16,17
In contrast, the factors related to the patient’s personal-
ity, preoperative quality of life and postoperative pain were 
associated with an IES-R score higher than 22 at the 3-month 
follow-up assessment (Table 2).18–20 Preoperative anxiety–
related symptoms and depression-related symptoms were 
associated with an IES-R score higher than 22 at the 3-month 
follow-up assessment. The preoperative anxiety–related 
symptoms component of the HADS score were above eight of 
15 participants (62%) of group A and six participants (26%) 
of group B, respectively (p = 0.03) (Table 2).16,17 The preoper-
ative depression–related symptoms component of the HADS 
score was above 8 in seven patients (29%) of group A, as 
compared with one patient (4.3%) of group B (p = 0.05). The 
preoperative PgWBI scores were of 68 (±19) in the patients 
of group A and 81 (±16) in those of group B (p = 0.02). This 
reflected a reduced preoperative quality of life in the patients 
of group A.
During the first 24 hours after surgery, a VAS
max
 score 
higher than 40 was found in 18 patients of group A, as com-
pared with 10 patients of group B (p = 0.05). The mean VAS 
scores over the 24 postoperative hours were 35 (±10) and 24 
(±20) in the patients of group A and those of group B at the 
3-month follow-up assessment (p = 0.004) (Table 3). The use 
of specific drugs or procedures did not differ between the 
patients according to their IES-R score. Among the patients 
with VAS higher than 40, 13 (46%), nine (32%), and seven 
(25%) received epidural analgesia, paravertebral block, or 
parenteral analgesics only (p = 0.6). The occurrence of post-
operative complications did not affect the IES-R score.
Time between the first surgical consultation and the sur-
gical procedure was similar in the two groups (32 days [±26 
[group A] and 26 days [±12] [group B]; p = 0.93). No signifi-
cant correlation was found between this time and the occur-
rence of PTSD (r = −0.11, p = 0.47). Metastatic cancer was 
diagnosed in 11 patients (46%) in group A and 10 (43%) in 
group B (p = 0.9).
Through a hierarchical linear regression we examined 
entering factors that were identified by the univariate analy-
sis. Because of the size of our cohort, only selected factors 
were entered into the model: preoperative anxiety–related 
symptoms (HADS
anxiety
 score > 7; p = 0.02), preoperative 
depression–related symptoms (HADS
depression
 > 7; p = 0.06), 
TABLE 1.  Features of the 47 Included Patients
Features
Group A
(n = 24)
Group B
(n = 23) p
Age, yrs (mean ± SD) 58 ± 10 61 ± 15 0.2
Male sex (%) 11 (46) 15 (65) 0.3
Married (%) 20 (83) 19 (83) 1.0
Retired (%) 10 (42) 13 (57) 0.4
Level of education (college) (%) 9 (38) 13 (63) 0.3
Body mass index (mean ± SD) 25 ± 6 26 ± 5 0.1
American Society of Anesthesiology 1(%)
American Society of Anesthesiology 2 (%)
American Society of Anesthesiology 3 (%)
7 (29)
13 (54)
4 (17)
5 (22)
13 (57)
5 (22)
0.8
Coronary artery disease (%) 2 (8) 4 (17) 0.6
Chronic obstructive pulmonary disease (%) 2 (8) 3 (13) 0.9
Chronic renal disease (%) 2 (8) 3 (13) 0.6
Diabetes (%) 3 (13) 3 (13) 1.0
History of tobacco use (%) 19 (79) 16 (70) 0.7
Alcohol consumption (%) 4 (17) 2 (9) 0.7
Psychiatry history (%) 4 (17) 4 (17) 1.0
Cancer history (%) 13 (54) 18 (78) 0.2
Prior cancer surgery (%) 12 (50) 13 (56) 0.9
History of radiotherapy (%) 4 (17) 7 (30) 0.4
History of chemotherapy (%) 9 (37) 8 (35) 0.9
Preoperative use of β-blockers (%) 3 (12) 5 (22) 0.5
Preoperative use of antidepressant (%) 3 (12) 2 (9) 1.0
Preoperative use of benzodiazepine (%) 5 (21) 4 (17) 0.9
Cancer diagnosis (%) 22 (87) 19 (82) 0.7
Secondary location (pulmonary) (%) 8 (33) 7 (30) 0.9
Other secondary locations (other than 
pulmonary) (%)
3 (13) 3 (13) 1.0
TABLE 2.  Psychological Characteristics
Features
Group A
(n = 24)
Group B
(n = 23) p
Symptoms of preoperative anxiety (HADS) (%) 15 (62) 6 (26) 0.03
Symptoms of preoperative depression (HADS) (%) 7 (29) 1 (4) 0.05
Preoperative PgWBI (mean ± SD) 68 ± 19 81 ± 16 0.02
Preoperative IES-R (mean ± SD) 28 ± 16 19 ± 17 0.02
IES-R at discharge (mean ± SD) 32 ± 15 23 ± 16 0.05
Symptoms of postoperative anxiety at 3 months (HADS) (%) 11 (46) 4 (17) 0.07
Symptoms of postoperative depression at 3 months (HADS) (%) 10 (42) 2 (9) 0.02
Postoperative PgWBI at 3 months (mean ± SD) 61 ± 24 79 ± 18 0.01
Postoperative IES-R at 3 months (mean ± SD) 42 ± 18 9 ± 7 < 0.001
IES-R, impact of events scale revised; HADS, Hospital Anxiety and Depression Scale; PgWBI, Psychological Well-Being Index.
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preoperative quality of life (PgWBI, global score; p = 0.06), 
and VAS
max
 during the first 24 hours after surgery higher than 
40 (p = 0.002).16,17 An IES-R score higher than 22 was pre-
dicted by preoperative HADS
anxiety
 score higher than 8 and a 
VAS
max
 higher than 40 during the first 24 hours. Patients with a 
preoperatorive HADS
anxiety
 score higher than 7 and a maximal 
VAS score higher than 40 during the first 24 hours after sur-
gery were more likely to develop PTSD-related symptoms at 
3 months with odd ratios at 4.61 [1.20–17.73] (p = 0.03) and 
1.34 [1.05–1.75] (p = 0.02), respectively (Table 4).18–20 The 
discrimination of these two variables was satisfactory with 
an area under the receiver operating characteristic curve esti-
mated at 0.8 (95% confidence interval [0.7–0.9], p < 0.001) 
(Fig. 1). The calibration was adequate. The difference was 
not significant between the rates of the predicted cases and 
observed cases (p = 0.65 using Hosmer–Lemeshow test). 
The exclusion of patients with nonmalignant lesions did not 
change the significance of these results (Table 4).
Finally, the postoperative VAS scores were 40 [2–50] 
in the patients with preoperative anxiety–related symptoms 
(HADS
anxiety
 score > 7), as compared with 45 [15–65] in those 
without preoperative anxiety–related symptoms (HADS
anxiety
 
score ≤ 7) (p = 0.46).16,17
DISCUSSION
In our cohort, 3 months after lung cancer resection, the 
prevalence of PTSD-related symptoms was 51%. Preoperative 
anxiety–related symptoms and postoperative pain seem to 
trigger the development of PTSD-related symptoms at the 
3-month follow-up assessment. Hence, to prevent the devel-
opment of PTSD-related symptoms, one may hypothesize the 
need for an aggressive pain management and an early iden-
tification of anxiety-related symptoms. The prevalence of 
 PTSD-related symptoms was evaluated using the IES-R score 
with a cutoff at 22.18–20,23 The high prevalence that we found 
can be explained by the nature of the underlying disease of our 
patients. Lung cancer can serve as model of aggression at the 
intersection between three causes of stress symptoms.
The stress symptoms can be because of the lung resec-
tion itself. This surgical procedure is associated with a high 
lethal related risk observed in elective surgery. Previous studies 
showed that PTSD-related symptoms were found in 32%, 25%, 
and 15% of patients undergoing abdominal aortic repair or 
coronary artery bypass, secondary peritonitis, and native valve 
replacement, respectively.24–26 In patients undergoing coronary 
artery bypass grafting procedures, depression and PTSD were 
associated with an increase of risk of death by a magnitude 
comparable with well-established physical health risk factors 
after coronary artery bypass grafting surgery.27 Thus, the surgi-
cal procedure itself may generate the reported stress symptoms.
The stress symptoms can be related to impaired func-
tional outcomes after the lung surgery. Lung cancer resection 
is associated with a worsening of short-form-36 subscales for 
TABLE 4.  Results of the multivariate analysis (symptoms 
for depression [HADS] and PGWB score at the preoperative 
assessment were excluded from analysis (p = 0.4 and p = 0.3, 
respectively)
p OR [95%CI]
All patients with suspected cancer
  Symptoms for anxiety (HADS) 0.03 4.6 [1.2–17.8]
  VAS
max
 (during the first 24 hr) 0.02 1.3 [1.1–1.8]
All patients with cancer
  Symptoms for anxiety (HADS) 0.02 1.4 [1.1–1.9]
  VAS
max
 (during the first 24 hr) 0.0004 1.10 [1.04–1.12]
OR, odds ratio; CI, confident interval; VAS, visual analogic scale; HADS, Hospital 
Anxiety and Depression Scale; PgWB, Psychological Well-Being Index.
FIGURE 1.  Receiver operating characteristic curve: 
Prediction of IES-R score > 22 at the 3-month assessment 
(logit=1.676 – (1.529 ×Anxiety) − (0.295 × VASmax), pc = 1/
(1+exp(logit)) Area under the curve: 0.81 CI95% (0.68–0.93; 
p < 0.001). VAS, visual analogic scale; CI, confident interval; 
IES-R, impact of events scale revised.
TABLE 3.  Postoperative Characteristics
Features
Group A
(n = 24)
Group B
(n = 23) p
Postoperative use of benzodiazepine 12 (50) 3 (13) 0.01
Postoperative use of antidepressant 3 (13) 2 (9) 1.0
Postoperative betablockers 4 (17) 4 (17) 1.0
Postoperative renal failure 1 (4) 3 (13) 0.3
Respiratory complications 5 (21) 3 (13) 0.7
Epidural catheter 10 (42) 9 (39) 0.9
Paravertebral block 9 (38) 8 (35) 0.9
Use of ketamine 18 (75) 20 (87) 0.5
Maximal VAS during the first 24 hr (mean ± SD) 5.9 ± 2.0 4.8 ± 2.1 0.05
Mean VAS during the first 24 hr (mean ± SD) 3.5 ± 1.1 2.4 ± 2.0 0.04
Maximal VAS at day 0 4.7 ± 2.9 2.5 ± 3.1 0.002
VAS > 40 at day 0 18 10 0.05
Results are expressed as absolute number (percentage).
VAS, visual analogic scale.
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physical functioning, role-physical, bodily pain, and mental 
health, as compared with the preoperative values.28 In breast 
cancer, a reduced physical functioning at 3 months was iden-
tified as an independent risk factor for PTSD-related symp-
toms.29 We used the PgWBI score to assess the quality of life. 
The high PTSD-related scores in the patients suggests that they 
developed feelings of anxiety, depressed mood, distress, loss of 
self-control, and lack of vitality.13 Our study did not explore the 
long-term effect of PTSD on outcomes. In trauma patients, a 
previous study showed that the median time to remission was 
around 25 months, and in more than one third of cases PTSD 
persisted for more than 60 months.30 Hence, the reported stress 
symptoms can be because of impaired functional outcomes.
The diagnosis of cancer itself may be associated with the 
development of PTSD-related symptoms. In female patients 
undergoing gynecological surgery, a diagnosis of cancer was 
associated with a 34% prevalence of PTSD-related symptoms, 
whereas that of a nonmalignant disease was associated with a 
15% prevalence.31 Similarly, the prevalence of PTSD-related 
symptoms increased in male patients undergoing radical pros-
tatectomy if the diagnosis was prostate cancer.32 Thus, lung 
cancer resection seems to generate stress because of various 
factors that act synergistically between themselves.
A VAS score higher than 40 after surgery was an inde-
pendent factor of PTSD-related symptoms. We did not iden-
tify an independent relation between PTSD-related symptoms 
and drugs used to relieve pain. Elsewhere, the use of mor-
phine was associated with a reduced development of PTSD 
symptoms.33,34 Ketamine has also been identified as protec-
tive in burned patients.35 All our patients had a dedicated pro-
tocol for pain relief using a multimodal approach. Of note, 
 patient-controlled analgesia or epidural analgesia had no spe-
cific effect on the development of PTSD-related symptoms. 
This underlines the fact that the critical point is the global 
management of pain rather than a specific procedure. This 
finding is in line with the concept of “sensitivity to pain trau-
matization,” which is strongly correlated with the development 
of PTSD-related symptoms.36 However, the use of analgesics 
by itself may affect the long-term outcomes of the patients.37
The preoperative screening of patients with anxiety 
symptoms can serve to identify those at high risk of devel-
oping PTSD-related symptoms after lung cancer resection. 
The hallmark of PTSD-related symptoms is the persistence 
of severe, disabling anxiety after a life-threatening event. In 
cancer, the operation passes but the threat does not resolve. 
Thus, as shown by our results, anxiety remains a persistent 
cause and the threat of annihilation is not lifted until much 
later, if at all.38 This finding has already been reported after 
various procedures.39,40 We confirmed here the negative impact 
of anxiety on the quality of life after lung surgery, which was 
suggested in a previous study.
Anxiety-related symptoms should be screened with 
attention. They are correlated to the rate of readmission after 
coronary artery bypass graft.41 As previous studies showed a 
protective role for β-adrenergic antagonist in women or pre-
operative use of a stress dose of hydrocortisone,42,43 one can 
expect future studies to test an antianxiety drug in patients 
undergoing lung cancer surgery. Elsewhere, PTSD-related 
symptoms were successfully reduced by the use of sero-
tonin inhibitor medication.44,45 Similarly, early psychological 
interventions can reduce acute stress symptoms.46 Then, the 
screening of these patients can result in an effective manage-
ment, improving their outcomes. Of note, we clearly show that 
pain and anxiety are not related because the two variables are 
independently identified in our multivariate analysis. In addi-
tion, no difference in pain intensity was found between the 
anxious and nonanxious participants.
Our study has several limitations that deserve to be dis-
cussed. The number of patients is relatively small. In addition, 
it is a single-center study. However, the size of our cohort is 
in agreement with that of previous studies on this topic.39,47–49 
Because ICU admission is an independent cause of PTSD,35 
we excluded from our analysis the patients undergoing pneu-
monectomy. Indeed, in our institution, these patients were 
admitted to ICU after surgery. However, to avoid secondary 
exclusion, two patients admitted to the ICU for unexpected 
complications were included in the analysis. One can suggest 
that considering only anatomical resections may be mislead-
ing by creating a bias excluding more compromised patients. 
Another potential bias was the stage of the disease process. 
First, the baseline of the patient was obtained the day before 
surgery. Then, we assessed our patients 3 months after the sur-
gical procedure. For several patients, the disease was probably 
diagnosed several weeks before this event. This may not be the 
best baseline given the nature of the disease. Thus, the course 
of the disease was actually longer than our 3-month measure. 
The trigger of the PTSD-related symptoms may be indepen-
dent of the surgical procedure. This can perhaps explain the 
high prevalence of PTSD-related symptoms that is reported 
in the present study. However, we did not find a correlation 
between the first surgical consultation and the surgical proce-
dure. This indirectly suggests that this factor is not critical. The 
least bias was the interview (IES-R), which assesses symp-
toms of PTSD but not confirmed diagnosis. On the basis of 
current literature, the structured interview remains the defini-
tive standard in the diagnosis of PTSD.50,51 Some studies have 
used the IES-R as a screening tool, but the cutoff changes by 
study and has not been validated, and an IES-R score does not 
make a diagnosis of PTSD. Our study looks at patients having 
symptoms associated with PTSD, using a cutoff in the IES-R 
found in other studies but not validated. As such, these symp-
toms are also associated with other non-PTSD diagnoses.
In conclusion, our study shows that PTSD-related symp-
toms are frequent after lung cancer resection. This is the first 
study to highlight a clear relation between postoperative pain 
and the development of PTSD-related symptoms in lung can-
cer patients. In addition, preoperative anxiety–related symp-
toms should be carefully screened for detecting the patients 
at risk of PTSD-related symptoms. These are preliminary 
findings, and need replications with larger sample size. Also, 
future studies should focus on interventions aimed at altering 
these factors and measure the use of postoperative morphine, 
which has not been possible here. Our future studies should 
also focus on structured interviews with paired blind experts 
to identify patients with confirmed diagnoses of PTSD, and 
then conduct the analysis on that cohort.
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